Literature DB >> 23775741

Complement-dependent cytotoxicity crossmatch.

Jeremy Ryan Peña1, Donna Fitzpatrick, Susan L Saidman.   

Abstract

The complement-dependent cytotoxic crossmatch is an informative test that detects alloantibodies in pre- and post-transplant patients, which may dictate clinical management of transplant patients. While challenging to perform, the cytotoxic crossmatch represents the only assay that provides direct evidence for the presence of potentially pathologic (i.e., cytotoxic) alloantibodies. The cytotoxic crossmatch combines patient (recipient) serum and donor cells. If donor-reactive alloantibodies are present in patient serum, these antibodies can bind donor cells. Antibody-antigen complexes, in turn, can activate the complement cascade, leading to complement-mediated cytotoxicity. Two commonly performed cytotoxic crossmatches, using donor lymphocytes as target cells, are described.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23775741     DOI: 10.1007/978-1-62703-493-7_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

Review 1.  Acute rejection.

Authors:  Mark Benzimra; Greg L Calligaro; Allan R Glanville
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

2.  Comparative analysis of Luminex-based donor-specific antibody mean fluorescence intensity values with complement-dependent cytotoxicity & flow crossmatch results in live donor renal transplantation.

Authors:  Ajay Kumar Baranwal; Deepali Krishan Bhat; Sanjeev Goswami; Sanjay Kumar Agarwal; Gurvinder Kaur; Jasmeet Kaur; Narinder Mehra
Journal:  Indian J Med Res       Date:  2017-02       Impact factor: 2.375

3.  Comparison of Physical Crossmatch and Virtual Crossmatch to Identify Preexisting Donor-Specific Human Leukocyte Antigen (HLA) Antibodies and Outcome Following Kidney Transplantation.

Authors:  Bo Peng; Quan Zhuang; Meng Yu; Junhui Li; Yun Liu; Lijun Zhu; Yingzi Ming
Journal:  Med Sci Monit       Date:  2019-02-03

4.  Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis.

Authors:  Mary Carmelle Philogene; Anita Amin; Sheng Zhou; Olga Charnaya; Renato Vega; Niraj Desai; Alicia M Neu; Cozumel S Pruette
Journal:  Pediatr Nephrol       Date:  2019-10-10       Impact factor: 3.714

5.  Immunological Aspects Involved in the Degeneration of Cryopreserved Arterial Allografts.

Authors:  Mario González-Gay; Rocío López-Martínez; Sara Busto-Suárez; Mariel Estefanía Riedemann-Wistuba; María Ángeles Menéndez-Herrero; Francisco Álvarez-Marcos; Manuel Alonso-Pérez; Rebeca Alonso-Arias
Journal:  Front Surg       Date:  2020-12-22

6.  A Comprehensive Evaluation of the Antibody-Verified Status of Eplets Listed in the HLA Epitope Registry.

Authors:  Suzanne Bezstarosti; Kim H Bakker; Cynthia S M Kramer; Johan W de Fijter; Marlies E J Reinders; Arend Mulder; Frans H J Claas; Sebastiaan Heidt
Journal:  Front Immunol       Date:  2022-01-28       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.